Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

A Phase II/III Clinical Trial to Evaluate the Effect of IAE0972 Combined with Chemotherapy Selected by Doctors for Recurrent or Metastatic Head and Neck Squamous Cell Carcinoma/Nasopharyngeal Carcinoma.

NCT06719479 is registered in ClinicalTrials.gov with SUNHO（China）BioPharmaceutical CO., Ltd. as lead sponsor.

NCT NCT06719479
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT06719479 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
A Phase II/III Clinical Trial to Evaluate the Effect of IAE0972 Combined with Chemotherapy Selected by Doctors for Recurrent or Metastatic Head and Neck Squamous Cell Carcinoma/Nasopharyngeal Carcinoma.
Lead sponsor
SUNHO（China）BioPharmaceutical CO., Ltd.
Phase
Phase 2/3
Overall status
Not yet recruiting
Start date
January 1, 2025
Completion date
January 1, 2028
Enrollment
60 (estimated)
Sites
Not reported

Conditions

As the registry lists them; a condition with its own page is linked.

hnscc, metastasis, npc, recurrence